136 related articles for article (PubMed ID: 11005692)
1. Oral fluoropyrimidines in the treatment of colorectal cancer.
Bissett D; Ahmed F; McLeod H; Cassidy J
Clin Oncol (R Coll Radiol); 2000; 12(4):240-5. PubMed ID: 11005692
[No Abstract] [Full Text] [Related]
2. [Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain].
Croockewit AJ; de Boer JE; van Loenhout JW; Koopmans PP
Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1117-20. PubMed ID: 12092301
[TBL] [Abstract][Full Text] [Related]
3. Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer.
Ignoffo RJ
Am J Health Syst Pharm; 1999 Dec; 56(23):2417-28; quiz 2428-9. PubMed ID: 10595802
[TBL] [Abstract][Full Text] [Related]
4. Oral fluoropyrimidines in the treatment of colorectal cancer.
Meropol NJ
Eur J Cancer; 1998 Sep; 34(10):1509-13. PubMed ID: 9893621
[TBL] [Abstract][Full Text] [Related]
5. Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.
Hoff PM; Lassere Y; Pazdur R
Drugs; 1999; 58 Suppl 3():77-83. PubMed ID: 10711845
[TBL] [Abstract][Full Text] [Related]
6. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
[No Abstract] [Full Text] [Related]
7. Oral fluoropyrimidines in colorectal cancer.
Van Cutsem E; Peeters M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
[No Abstract] [Full Text] [Related]
8. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
9. Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer.
Cunningham D; James RD
Eur J Cancer; 2001 May; 37(7):826-34. PubMed ID: 11313169
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
[TBL] [Abstract][Full Text] [Related]
11. Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?
Lokich J
Cancer Invest; 2001; 19(8):854-7. PubMed ID: 11768039
[No Abstract] [Full Text] [Related]
12. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
13. Applications of oral fluoropyrimidines in colon cancer: their role and new directions.
Benson AB
J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-17-21. PubMed ID: 23570133
[No Abstract] [Full Text] [Related]
14. Oral fluoropyrimidines in cancer treatment.
Lewis NL; Meropol NJ
Cancer Invest; 2000; 18(8):747-60. PubMed ID: 11107445
[No Abstract] [Full Text] [Related]
15. Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure.
Alkis N; Demirci U; Benekli M; Yilmaz U; Isikdogan A; Sevinc A; Ozdemir NY; Koca D; Yetisyigit T; Kaplan MA; Uncu D; Unek T; Gumus M
J BUON; 2011; 16(1):80-3. PubMed ID: 21674854
[TBL] [Abstract][Full Text] [Related]
16. [Tegafur.uracil for treatment of colorectal cancer].
Fujii M
Nihon Rinsho; 2003 Sep; 61 Suppl 7():349-51. PubMed ID: 14574910
[No Abstract] [Full Text] [Related]
17. Oral fluoropyrimidine treatment of colorectal cancer.
Eng C; Kindler HL; Schilsky RL
Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinoma.
Hoff PM; Pazdur R
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):48-50. PubMed ID: 10442361
[TBL] [Abstract][Full Text] [Related]
19. [5 -fluoropyrimidines for treatment of biliary tract cancers].
Morizane C; Okusaka T; Ueno H; Ikeda M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():529-33. PubMed ID: 16457319
[No Abstract] [Full Text] [Related]
20. Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis.
Ogata Y; Torigoe S; Matono K; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Mizobe T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
Int Surg; 2007; 92(6):314-9. PubMed ID: 18402123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
